Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | May 2012 |
| End Date: | July 2013 |
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
This is a prospective, non-randomized, observational study conducted in the United States.Up
to sixty (60) subjects will be enrolled. The purpose of the study is to evaluate long-term
utility and usability of Dexcom G4 Continuous Glucose Monitoring (CGM) System. Subjects will
be followed monthly over a period of one year.
Inclusion Criteria:
- Require intensive insulin therapy, defined as use of Continuous Subcutaneous Insulin
Infusion (CSII) i.e. insulin pumps or multiple daily injections (MDI.
- Willing to refrain from use of any acetaminophen - containing (ACT) medication
during the study, up to 24-hours before the initial sensor insertion.
Exclusion Criteria:
- Have extensive skin changes/ diseases that preclude wearing the device.
- Dialysis.
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials